Premium
Re‐challenging with anti‐CD38 monotherapy in triple‐refractory multiple myeloma patients is a feasible and safe approach
Author(s) -
Alici Evren,
Chrobok Michael,
Lund Johan,
Ahmadi Tahamtan,
Khan Imran,
Duru Adil D.,
Nahi Hareth
Publication year - 2016
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13776
Subject(s) - medicine , multiple myeloma , refractory (planetary science) , daratumumab , lenalidomide , oncology , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom